Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Dr. Edwin Moses, Chairman, NanoSyrinx
    10 September 2024

    NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman

    Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of the technology plat...

    Cleanroom Solutions are facilitating great work in Life Sciences
    11 September 2024

    HOPE: Cleanroom Solutions facilitating greatness with elite large-scale turnkey construction builds

    Guardtech Group’s complex cleanroom facility construction brand celebrating their role as facilitators of groundbreaking Life Science and R&D innovation ...

    3 white woman and 1 white mean standing in a College garden smiling at the camera with drinks in their hands
    10 September 2024

    Meet Cambridge helps to bring international neurotrauma conference to the city

    The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field. ...

    Heat map from CiliaBeat software  demonstrating distribution of actively beating ciliated cells with colour-coded beat frequency
    9 September 2024

    Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development

    Application of new CiliaBeat software to provide reliable and predictive data on the impact of drugs on cilia function Assay leverages Newcells’ complex lung small airway in vitro model to enable highly sensitive assessment of drug efficacy and chemical safety as part of expanded se...

    Overcoming Obstacles in Medical Device Innovation
    6 September 2024

    Overcoming obstacles in medical device innovation

    Co-authored by Samantha Shelley, SQMS

    Lingang
    4 September 2024

    Unlocking opportunities in China's thriving Life Sciences market

    As the second-largest healthcare market in the world, China is on an extraordinary trajectory of growth, with its life sciences sector expected to triple in size by 2030. This is an exciting time for UK life science companies looking to expand their horizons. Excellence First Enterprise...

    John E Milad, CEO, ERS Genomics
    4 September 2024

    ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement

    Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications Dublin, Ireland, and Cheshire, UK: ERS Genomics Limited, the CRISPR licensing Company, and Medicines Discovery Catapult, an independent, not...

    idiopathic pulmonary fibrosis
    4 September 2024

    From farms to factories: patient journey to Pulmonary Fibrosis

    Rosemary’s health journey has been anything but straightforward. After enduring three years of painful breathing tests with countless visits to her GP and specialist consultants, she was finally given a diagnosis 12 months later—a name that escaped her when her granddaughter asked. Havi...

    Sapio Sciences
    3 September 2024

    Sapio Sciences advances the world's first AI-powered lab assistant

    Sapio ELaiN couples AI and natural language processing to deliver the future interface for scientists and lab operations Baltimore, MD, 03 September 2024 – Sapio Sciences, the science-aware™ lab informatics platform,  announces significant enhancements to Sapio ELaiN, the pioneeri...

    L – R Dr Xand, and BioResource staff Kathy, Katy, Alimat, Grace
    29 August 2024

    Dr Xand takes a visit to the BioResource laboratory

    D-CYPHR ambassador checked out the exciting new technology used to decode the DNA provided by our volunteers. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 129
    • Page 130
    • Current page 131
    • Page 132
    • Page 133
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS